The FDA approves a new type of schizophrenia drug

U.S. FDA approves Boehringer’s JASCAYD® (nerandomilast tablets) as first new treatment option for adults with IPF in over a decade

FDA approves new obesity drug

Medical Devices

FDA Registration and Listing for Medical Devices

FDA Medical Device Registration: Process Overview

FDA unveils drugs to receive expedited review in support of 'national priorities'

Rare Disease Research Advocates Testify on the Impact of FDA Regulation